Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ADGM Stock Forecast 2026-2027
$1.02
Current Price
$21.60M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ADGM Price Targets
+292.2%
To High Target of $4.00
+292.2%
To Median Target of $4.00
+292.2%
To Low Target of $4.00
ADGM Price Momentum
+4.1%
1 Week Change
+3.0%
1 Month Change
-1.0%
1 Year Change
-1.9%
Year-to-Date Change
-64.5%
From 52W High of $2.87
+63.2%
From 52W Low of $0.63
📊 TOP ANALYST CALLS
Did ADGM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Adagio Medical is one of their latest high-conviction picks.
Latest ADGM Stock Price Targets & Analyst Predictions
Based on our analysis of 1 Wall Street analyst, ADGM has a bullish consensus with a median price target of $4.00 (ranging from $4.00 to $4.00). The overall analyst rating is N/A (N/A/10). Currently trading at $1.02, the median forecast implies a 292.2% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Frank Takkinen at Lake Street, projecting a 292.2% upside. Conversely, the most conservative target is provided by Frank Takkinen at Lake Street, suggesting a 292.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ADGM Analyst Ratings
1
Buy
0
Hold
0
Sell
ADGM Price Target Range
Low
$4.00
Average
$4.00
High
$4.00
Current: $1.02
Latest ADGM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ADGM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 2, 2025 | Lake Street | Frank Takkinen | Buy | Initiates | $4.00 |
Adagio Medical Holdings Inc. (ADGM) Competitors
The following stocks are similar to Adagio Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Adagio Medical Holdings Inc. (ADGM) Financial Data
Adagio Medical Holdings Inc. has a market capitalization of $21.60M with a P/E ratio of -0.4x. The company generates $137,000 in trailing twelve-month revenue with a -335.3% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -19,543.8% and return on equity of -210.4%.
Valuation Metrics
Market Cap
$21.60M
Enterprise Value
$38.05M
P/E Ratio
-0.4x
PEG Ratio
0.0x
Price/Sales
151.5x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
-19,543.8%
Net Margin
-335.3%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+21.7%
Current Ratio
0.8x
Debt/Equity
-16.7x
ROE
-210.4%
ROA
-24.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Adagio Medical Holdings Inc. (ADGM) Business Model
About Adagio Medical Holdings Inc.
What They Do
Develops innovative solutions for cardiac arrhythmias.
Business Model
The company generates revenue by developing and selling advanced medical equipment and systems for treating heart rhythm disorders, particularly through its novel cryoablation technology platform. This technology allows for precise therapies that improve patient outcomes, and it collaborates with healthcare professionals to align its products with clinical needs.
Additional Information
Adagio Medical Holdings is positioned in the growing medical technology market, focusing on advancements in electrophysiology and cardiovascular treatment. Their work is increasingly important as the global population ages and cardiac disorders become more prevalent, making their innovations critical for improving healthcare outcomes.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
80
CEO
Mr. Todd Usen
Country
United States
IPO Year
2024
Website
adagiomedical.comAdagio Medical Holdings Inc. (ADGM) Latest News & Analysis
Latest News
Quick Summary
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) will participate in the 38th Annual Roth Conference on March 23-24, 2026, hosting one-on-one investor meetings.
Why It Matters
Adagio Medical's participation in the Roth Conference signals potential growth opportunities and investor engagement, which can positively influence stock performance and market perception.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) will present at the TD Cowen Healthcare Conference on March 3, 2026, at 2:30 PM ET. A live webcast will be available online.
Why It Matters
Adagio Medical's presentation at a major healthcare conference could signal potential growth and innovation in its catheter ablation technologies, influencing investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) will participate in the BTIG 13th Annual MedTech Conference on February 10, 2026, in Snowbird, UT, focusing on catheter ablation technologies.
Why It Matters
Adagio Medical's participation in a major conference highlights its commitment to innovation and could attract investor interest, potentially impacting stock performance and market perception.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Adagio Medical Holdings, Inc. announced results from a U.S. Early Feasibility Study on ultralow temperature cardiac ablation for scar-related ventricular tachycardia, published in Circulation: Arrhythmia.
Why It Matters
Positive study results for Adagio's ultralow temperature cardiac ablation technology may enhance its market position, potentially boosting stock value and attracting investor interest.
Source: Business Wire
Market Sentiment:
Neutral
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
1 month ago
Quick Summary
The company is hosting an online event for individual and institutional investors, advisors, and analysts at VirtualInvestorConferences.com.
Why It Matters
The invitation indicates the company is seeking to engage with a broad audience, potentially signaling confidence and transparency, which could positively influence investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness
2 months ago
Quick Summary
Adagio Medical Holdings, Inc. has appointed Marie-Claude Jacques as Senior VP of Global Sales and Antwan Gipson as Senior VP of Manufacturing and Operations, marking a key step toward commercialization.
Why It Matters
Leadership changes at Adagio Medical could enhance strategic direction and operational efficiency, potentially leading to improved sales and market performance, impacting investor sentiment positively.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About ADGM Stock
What is Adagio Medical Holdings Inc.'s (ADGM) stock forecast for 2026?
Based on our analysis of 1 Wall Street analysts, Adagio Medical Holdings Inc. (ADGM) has a median price target of $4.00. The highest price target is $4.00 and the lowest is $4.00.
Is ADGM stock a good investment in 2026?
According to current analyst ratings, ADGM has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.02. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ADGM stock?
Wall Street analysts predict ADGM stock could reach $4.00 in the next 12 months. This represents a 292.2% increase from the current price of $1.02. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Adagio Medical Holdings Inc.'s business model?
The company generates revenue by developing and selling advanced medical equipment and systems for treating heart rhythm disorders, particularly through its novel cryoablation technology platform. This technology allows for precise therapies that improve patient outcomes, and it collaborates with healthcare professionals to align its products with clinical needs.
What is the highest forecasted price for ADGM Adagio Medical Holdings Inc.?
The highest price target for ADGM is $4.00 from Frank Takkinen at Lake Street, which represents a 292.2% increase from the current price of $1.02.
What is the lowest forecasted price for ADGM Adagio Medical Holdings Inc.?
The lowest price target for ADGM is $4.00 from Frank Takkinen at Lake Street, which represents a 292.2% increase from the current price of $1.02.
What is the overall ADGM consensus from analysts for Adagio Medical Holdings Inc.?
The overall analyst consensus for ADGM is bullish. Out of 1 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $4.00.
How accurate are ADGM stock price projections?
Stock price projections, including those for Adagio Medical Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 13, 2026 7:56 PM UTC